Karim Saad Temsamani - Dec 1, 2023 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Executive Officer, Director
Signature
/s/ NicK Lynton, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Dec 1, 2023
Transactions value $
-$331,791
Form type
4
Date filed
12/5/2023, 07:53 PM
Previous filing
Oct 3, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Options Exercise $0 +84.1K +39.07% $0.00 299K Dec 1, 2023 Direct F1
transaction CDLX Common Stock Sale -$332K -40.4K -13.5% $8.21 259K Dec 5, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Unit Options Exercise $0 -84.1K -8.33% $0.00 925K Dec 1, 2023 Common Stock 84.1K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the underlying vested shares of common stock of the Issuer.
F2 Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on December 1, 2023.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F5 25% of the RSUs vested on September 1, 2023 with the remaining 75% vesting in equal amounts over the subsequent three years quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.